|
0
|
|
Efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 trial.
(linkinghub.elsevier.com)
|
Bajaj HS
…
Bartee A
The Lancet
2026-06-13
|
#diabetes
#clinical trial
#obesity
#metabolism
#pharmacology
|
|
0
|
|
Methylphenidate enhances or impairs the cognitive control of Pavlovian bias depending on working memory capacity.
(elifesciences.org)
|
Geurts DEM
…
Cools R
eLife
2026-06-16
|
#cognition
#decision-making
#pharmacology
#neurotransmitter
|
|
0
|
|
Negative effects of semaglutide on bone in obese mice.
(linkinghub.elsevier.com)
|
Eisner K
…
Wright DC
Cell Reports Medicine
2026-06-18
|
#bone
#obesity
#metabolism
#pharmacology
|
|
0
|
|
Chemical ecology and convergent evolution of natural hallucinogens: From ecological defense to conserved neural targets.
(pnas.org)
|
Wang Y
…
Wang X
PNAS
2026-06-24
|
#chemical ecology
#alkaloids
#biosynthesis
#evolution
#pharmacology
|
|
0
|
|
Small-molecule modulation of beta-arrestins.
(nature.com)
|
Kahsai AW
…
Lefkowitz RJ
Nature
2026-06-24
|
#pharmacology
#signaling
#drug design
#structural biology
|
|
0
|
|
Correcting congenital myasthenia-associated acetylcholine receptor defects.
(nature.com)
|
Li H
…
Hibbs RE
Nature
2026-07-01
|
#myasthenia
#electrophysiology
#cryo-em
#neuromuscular
#pharmacology
|
|
0
|
|
Gut microbiota alters drug metabolism and therapeutic outcomes.
(linkinghub.elsevier.com)
|
Guo F
…
Lei X
Cell Host & Microbe
2026-07-08
|
#microbiome
#metabolism
#pharmacology
#therapeutics
#personalized medicine
|
|
0
|
|
Antibody-drug conjugates and the need for third-modality regulatory science.
(linkinghub.elsevier.com)
|
Jiang N
…
Li N
Cell Med
2026-07-10
|
#immunotherapy
#regulation
#pharmacology
#manufacturing
#oncology
|